The company’s transformation into just another pharmaceutical company – inevitable if the current ownership changes – would be an irreplaceable loss not just for India’s poor, but the entire global south
Cipla s potential stake sale faces a challenge due to disagreements among its promoters regarding the company s valuation. This dispute among the founders could potentially delay the deal until a consensus is reached on the valuation, according to sources cited by ET Now.